Alexis Ritvo, MD, MPH, BA

Assistant Professor, Psychiatry-CeDAR


FacultyPhoto
Medical School
  • MD, Emory University School of Medicine (2012)
Graduate School
  • MPH, Emory University Rollins School of Public Health (2012)
Undergraduate School
  • AB, Harvard University (MA) (2005)
Internship
  • University of Colorado (2013)
Residency
  • University of Colorado, Chief Resident, Psychiatry (2016)
Fellowships
  • University of Colorado, Addiction Psychiatry (2017)
Languages
English
Department
Psychiatry-CeDAR

Professional Titles

  • Program Director, Addiction Psychiatry Fellowship
  • Faculty Supervisor, CU Medicine Outpatient Psychiatry Clinic

Recognitions

  • Alexis Giese, MD Service Excellence Award, University of Colorado Department of Psychiatry (2016)
    In recognition of a resident who works to “improve the patient experience, improve the quality of care, and contribute to a more efficient and effective delivery system.”
  • Resident Recognition Award, American Psychiatric Association (2016)
    Presented annually to outstanding psychiatry residents or fellows from each department or institution who exemplifies one or more APA values.

Research Interests

Undergraduate, graduate and continuing medical education in substance use disorders as well as safe prescribing and deprescribing of benzodiazepines.

Publications

  • Yager J, Ritvo A, Wolfe JH, Feinstein RE. A Survival Guide to Low-Resource Peer-Reviewed Creative Scholarship for Aspiring Clinician-Educators. Acad Psychiatry. 2018 Dec;42(6):841-846. PubMed PMID: 30109545
  • Cummings JR, Wen H, Ritvo A, Druss BG. Health insurance coverage and the receipt of specialty treatment for substance use disorders among U.S. adults. Psychiatr Serv. 2014 Aug 1;65(8):1070-3. PubMed PMID: 25082606
  • Ritvo, AD. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine", 2020 American Society of Addiction Medicine (ASAM) Virtual Poster Abstracts. J Addict Med. 2020;14(6):e382-e424. doi:10.1097/ADM.0000000000000742. 
  • Ritvo, AD. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine- A Case Series. Association for Multidisciplinary Research and Education in Substance use and Addiction (AMERSA) Annual Conference. Virtual Oral Presentation. 11/2020.
  • Balasanova AA, Ritvo AD, Yager J. Addiction psychiatry and addiction medicine - Strange bedfellows or separated at birth?. Subst Abus. 2021;42(2):130-135. PubMed PMID: 33689603
  • Ritvo AD, Calcaterra SL, Ritvo JI. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series. J Addict Med. 2021 May-Jun 01;15(3):252-254. PubMed PMID: 32925232
  • Yager J, MacPhee ER, Ritvo AD, Salamander RM. Thirty-Minute Psychiatric Management Visits in Academic Medical Centers: Framing and Exploring Distinct Clinical-Educational Social Processes. J Nerv Ment Dis. 2022 Feb 1;210(2):77-82. PubMed PMID: 35080517
  • Balasanova AA, Ritvo A, Renner JA Jr. A call for increased addiction psychiatrist engagement in medical student education. Am J Addict. 2022 Sep;31(5):403-405. PubMed PMID: 36071591
  • Yager J, Ritvo AD, MacPhee ER. Psychiatrists' Cognitive and Affective Biases and the Practice of Psychopharmacology: Why Do Psychiatrists Differ From One Another in How They View and Prescribe Certain Medication Classes?. J Nerv Ment Dis. 2022 Oct 1;210(10):729-735. PubMed PMID: 35687788
  • Yager J, MacPhee ER, Ritvo AD, Salamander RM. Thirty-Minute Psychiatric Management Visits in Academic Medical Centers: Framing and Exploring Distinct Clinical-Educational Social Processes. J Nerv Ment Dis. 2022 Feb 1;210(2):77-82. PubMed PMID: 35080517
  • Ritvo AD, Foster DE, Huff C, Finlayson AJR, Silvernail B, Martin PR. Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey. PLoS One. 2023;18(6):e0285584. PubMed PMID: 37384788
  • Coyle DT, Stewart S, Bortz C, Manalo J, Ritvo A, Krsak M. Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals. Subst Abus. 2023 Jan-Apr;44(1):17-23. PubMed PMID: 37226901

Professional Memberships

  • American Psychiatric Association, Member
  • Colorado Psychiatric Society, Member
  • American Academy of Addiction Psychiatry, Member

Practice Locations

CU Medicine Psychiatry - Outpatient Clinic
1890 N Revere Ct
Anschutz Health Sciences Bldg, Suite 4020
Aurora, CO 80045
303-724-1000

Specialty Information

Specialties
  • Psychiatry, Board Certification (2016, 2016)
  • Addiction Psychiatry, Board Certification (2018, 2018)
  • University of Colorado Department of Psychiatry Psychotherapy Scholars' Track, Specialized Training (2016)
  • Denver Institute for Psychoanalysis' Psychodynamic Psychotherapy Training Program, Specialized Training (2018)
Conditions & Treatments
  • Substance Abuse
  • Mental Health and Behavior
  • Substance Abuse - Alcoholism
  • Substance Abuse - Drug Abuse
  • Substance Abuse - Smoking Cessation
Clinical Interests
Evaluating and treating co-occurring substance use disorders and other psychiatric disorders as well as prescription benzodiazepine deprescribing. I have a half day co-occurring disorder clinic where I directly supervise a 3rd or 4th year psychiatry resident seeing patients referred from UCHealth providers.

Public Speaking
Yes
Addiction Psychiatry. Safe prescribing and deprescribing of benzodiazepines.